Optimal Treatment on Hepatocellular Carcinoma (HCC) With Cirrhotic Portal Hypertension

NCT01642446 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
160
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Sun Yat-sen University